Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Therapeutic Drug Monitoring Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
5.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
5.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
5.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
5.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
5.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
5.2.5. By Region
5.2.6. By Company (2022)
5.3. Product Map
5.3.1. By Product
5.3.2. By Technology
5.3.3. By Class of Drug
5.3.4. By End User
5.3.5. By Region
6. North America Therapeutic Drug Monitoring Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
6.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
6.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
6.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
6.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
6.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Therapeutic Drug Monitoring Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Technology
6.3.1.2.3. By Class of Drug
6.3.1.2.4. By End- User
6.3.2. Canada Therapeutic Drug Monitoring Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Technology
6.3.2.2.3. By Class of Drug
6.3.2.2.4. By End- User
6.3.3. Mexico Therapeutic Drug Monitoring Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Technology
6.3.3.2.3. By Class of Drug
6.3.3.2.4. By End- User
7. Europe Therapeutic Drug Monitoring Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
7.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
7.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
7.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
7.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
7.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Therapeutic Drug Monitoring Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Technology
7.3.1.2.3. By Class of Drug
7.3.1.2.4. By End- User
7.3.2. United Kingdom Therapeutic Drug Monitoring Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Technology
7.3.2.2.3. By Class of Drug
7.3.2.2.4. By End- User
7.3.3. Italy Therapeutic Drug Monitoring Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Technology
7.3.3.2.3. By Class of Drug
7.3.3.2.4. By End- User
7.3.4. Germany Therapeutic Drug Monitoring Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Technology
7.3.4.2.3. By Class of Drug
7.3.4.2.4. By End- User
7.3.5. Spain Therapeutic Drug Monitoring Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Technology
7.3.5.2.3. By Class of Drug
7.3.5.2.4. By End- User
8. Asia-Pacific Therapeutic Drug Monitoring Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
8.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
8.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
8.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
8.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
8.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Therapeutic Drug Monitoring Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Technology
8.3.1.2.3. By Class of Drug
8.3.1.2.4. By End- User
8.3.2. India Therapeutic Drug Monitoring Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Technology
8.3.2.2.3. By Class of Drug
8.3.2.2.4. By End- User
8.3.3. Japan Therapeutic Drug Monitoring Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Technology
8.3.3.2.3. By Class of Drug
8.3.3.2.4. By End- User
8.3.4. South Korea Therapeutic Drug Monitoring Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Technology
8.3.4.2.3. By Class of Drug
8.3.4.2.4. By End- User
8.3.5. Australia Therapeutic Drug Monitoring Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Technology
8.3.5.2.3. By Class of Drug
8.3.5.2.4. By End- User
9. South America Therapeutic Drug Monitoring Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
9.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
9.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
9.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
9.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
9.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Therapeutic Drug Monitoring Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Technology
9.3.1.2.3. By Class of Drug
9.3.1.2.4. By End- User
9.3.2. Argentina Therapeutic Drug Monitoring Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Technology
9.3.2.2.3. By Class of Drug
9.3.2.2.4. By End- User
9.3.3. Colombia Therapeutic Drug Monitoring Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Technology
9.3.3.2.3. By Class of Drug
9.3.3.2.4. By End- User
10. Middle East and Africa Therapeutic Drug Monitoring Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
10.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
10.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
10.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
10.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
10.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Therapeutic Drug Monitoring Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Technology
10.3.1.2.3. By Class of Drug
10.3.1.2.4. By End- User
10.3.2. UAE Therapeutic Drug Monitoring Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Technology
10.3.2.2.3. By Class of Drug
10.3.2.2.4. By End- User
10.3.3. Saudi Arabia Therapeutic Drug Monitoring Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Technology
10.3.3.2.3. By Class of Drug
10.3.3.2.4. By End- User
10.3.4. Turkey Therapeutic Drug Monitoring Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product
10.3.4.2.2. By Technology
10.3.4.2.3. By Class of Drug
10.3.4.2.4. By End- User
10.3.5. Egypt Therapeutic Drug Monitoring Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Product
10.3.5.2.2. By Technology
10.3.5.2.3. By Class of Drug
10.3.5.2.4. By End- User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Product Launches
12.2. Mergers & Acquisitions
12.3. Technological Advancements
13. Global Therapeutic Drug Monitoring Market: SWOT Analysis
14. Competitive Landscape
14.1. Roche AG
14.1.1. Business Overview
14.1.2. Product Offerings
14.1.3. Recent Developments
14.1.4. Financials (In Case of Listed Companies)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Siemens Healthcare GmbH
14.3. Thermo Fisher Scientific, Inc.
14.4. Bio-Rad Laboratories, Inc.
14.5. Beckman Coulter, Inc.
14.6. Abbott Laboratories, Inc.
14.7. Agilent Technologies, Inc.
14.8. bioM?rieux, Inc.
14.9. Alere, Inc.
15. Strategic Recommendations